ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?

Detalles Bibliográficos
Autores principales: Kauffenstein, Gilles, Chappard, Daniel, Leftheriotis, Georges, Martin, Ludovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796561/
https://www.ncbi.nlm.nih.gov/pubmed/35771123
http://dx.doi.org/10.1111/exd.14636
_version_ 1784860513925070848
author Kauffenstein, Gilles
Chappard, Daniel
Leftheriotis, Georges
Martin, Ludovic
author_facet Kauffenstein, Gilles
Chappard, Daniel
Leftheriotis, Georges
Martin, Ludovic
author_sort Kauffenstein, Gilles
collection PubMed
description
format Online
Article
Text
id pubmed-9796561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97965612022-12-30 ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum? Kauffenstein, Gilles Chappard, Daniel Leftheriotis, Georges Martin, Ludovic Exp Dermatol Research Letters John Wiley and Sons Inc. 2022-07-11 2022-10 /pmc/articles/PMC9796561/ /pubmed/35771123 http://dx.doi.org/10.1111/exd.14636 Text en © 2022 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letters
Kauffenstein, Gilles
Chappard, Daniel
Leftheriotis, Georges
Martin, Ludovic
ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title_full ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title_fullStr ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title_full_unstemmed ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title_short ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
title_sort abcc6 deficiency and bone loss: a double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796561/
https://www.ncbi.nlm.nih.gov/pubmed/35771123
http://dx.doi.org/10.1111/exd.14636
work_keys_str_mv AT kauffensteingilles abcc6deficiencyandbonelossadoublebenefitofetidronateforpatientpresentingwithpseudoxanthomaelasticum
AT chapparddaniel abcc6deficiencyandbonelossadoublebenefitofetidronateforpatientpresentingwithpseudoxanthomaelasticum
AT leftheriotisgeorges abcc6deficiencyandbonelossadoublebenefitofetidronateforpatientpresentingwithpseudoxanthomaelasticum
AT martinludovic abcc6deficiencyandbonelossadoublebenefitofetidronateforpatientpresentingwithpseudoxanthomaelasticum

Ejemplares similares